Under construction – not a live service
Sign in
Not yet taking people in GermanyNo phase

DEXA Bone Density Analysis of the CoreHip® Prosthesis System

Key facts

Where
Hanover, GermanySee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 35 and 85 years old?

Source: NCT06632301, who can take part

Where in Germany

  • Medizinische Hochschule HannoverHanover, GermanyContact: Henning WindhagenNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Aesculap AG
Trial code
NCT06632301
Record updated
16 October 2026
Original description
The goal of this interventional post-market follow-up study is to evaluate radiological changes in the diaphyseal bone density (Gruen Zones 3 and 4) within 24 months postoperative in patients treated with CoreHip® primary cementless stem. The DEXA bone density analysis is used.Read full original descriptionShow less

DEXA Bone Density Analysis to Analyze the Loading Concept of the CoreHip® Prosthesis

The goal of this interventional post-market follow-up study is to evaluate radiological changes in the diaphyseal bone density (Gruen Zones 3 and 4) within 24 months postoperative in patients treated with CoreHip® primary cementless stem. The DEXA bone density analysis is used.

Inclusion: Unilateral hip osteoarthritis; Indication for CoreHip Standard hip stem according to preoperative planning; Written Informed Consent; Age 35-85 years; According to the assessment of the study doctor, the patient is therapy compliant and able to attend the follow-up visits.

Exclusion: History of femoral fracture or previous surgery on the same hip; Metabolic bone disease, use of steroids or other drugs affecting bone metabolism; Femoral neck fractures; Pregnancy; BMI > 35; Intraoperative bone cracks; Severe osteoarthritis of the contralateral hip; THA of the contralateral side or other event leading to restricted weight bearing during the study period.

ClinicalTrials.gov NCT06632301